NVG-291 in Spinal Cord Injury Subjects

Clinical trial NCT05965700 · COMPLETED

Trial details

NCT number: NCT05965700
Sponsor: NervGen Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Spinal Cord Injuries Chronic Spinal Cord Injury Subacute Spinal Cord Injury

Start date: 2023-08-08
Primary completion: 2025-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.